🌎 MarketBeat Daily Premium: Daily Analysts' Updates for 2/9/2022

Ratings changes for GDS, US Ecology, Olema Pharmaceuticals, Penn National Gaming, Avidity Biosciences, Marker Therapeutics, Neurocrine Biosciences and more... View In Web Browser.
MarketBeat Daily Premium
VIEW MY PORTFOLIO right arrow
February 9th, 2022
Subscribe to the Official MarketBeat Podcast Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Follow MarketBeat on StockTwits Follow MarketBeat on Financial Juice
S and P pricesDow pricesQQQ prices
Today's Top Stories
Institutions Are Buying Alpha And Omega Semiconductor Limited
Watchdog says Brexit has brought cost, red tape for UK firms
Say Goodbye To your Smartphone (ad)
Buy Pfizer Before the Smart Money Catches On to the Plot
COVID-19 vaccines, prescriptions fuel strong quarter at CVS
Logitech is Nearing the Bottom Here
Tesla recall: Heat pump won't defrost windshield fast enough
Aw Snap!: The Buy Opportunity on Snap Stock is Disappearing Fast
Senators call for gas tax suspension to blunt rising prices
Small-Cap CTS Corporation Positioned For Big Business
CVS Health tops 4Q forecasts, reaffirms 2022 outlook
Exercise Stock Winners that Can Do the Heavy Lifting For You
Shipping company Maersk sees record profit as demand surges
Quick Links
Getting Started with MarketBeat All Access
completed Read Your Daily Newslettercompleted Check Out My MarketBeat
completed Watch Our Tutorial Videoscompleted Add a Stock to Your Watchlist
completed Set Up an Instant Alertcompleted View a Company's Profile Page
completed Customize Your Newsletternot completed View Current Brokerage Rankings
completed Check Out The Live News Feedcompleted Review Premium Reports
completed View The Idea Engine

Your Watchlist(s)
You have not added any stocks to your watchlist.

Click here to add stocks from your portfolio to your watchlist.



More Calendars from MarketBeat
U.S. Analyst Ratings, Canadian Analyst Ratings, U.K. Analyst Ratings, Corporate Buybacks, Cryptocurrencies, Dividend Declarations, Earnings Announcements, Earnings Conference Calls, Economic Reports, Gap Up/Down Stocks, Insider Trades, Initial Public Offerings (IPOs), Most Active Stocks, Percentage Gainers/Decliners, Sector Performance, Short Interest, Stock Splits, Unusual Options Volume & Unusual Trading Volume.

Export Data to Excel
MarketBeat Brokerage Ratings
Receive more information about MarketBeat's brokerage ratings and view the most recent ratings for all brokerages rated by MarketBeat.

CLICK HERE right arrow
Join Our Facebook Group
Join MarketBeat's free stock discussion and trading idea group on Facebook.

JOIN NOW right arrow

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.
If you would like to make changes to your premium subscription, click here to manage your account or unsubscribe.

© 2006-2022 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: New Cash Law Will Be Disaster for Saverspixel

Post a Comment

Please Select Embedded Mode To Show The Comment System.*

Previous Post Next Post